A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis

Clinical trial NCT00239382 · COMPLETED

Trial details

NCT number: NCT00239382
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2004-07-01
Primary completion: 2004-12-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.